FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.

The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded ...

The FDA's new vaccine guidelines focus on older adults, citing insufficient evidence for the need for additional COVID shots ...

The FDA is requiring COVID vaccine makers Pfizer and Moderna to update their warnings about the possible risk of myocarditis and pericarditis.

The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...

The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...

The Permanent Subcommittee on Investigations is set to hold its first hearing about the negative side effects of the COVID-19 vaccine. The committee issued a subpoena to the Department of Health and ...

On May 20, 2025, the Food and Drug Administration announced a new stance on who should receive the COVID-19 vaccine.

Under the new approach, updated Covid-19 vaccines are likely to be available this autumn only for people aged 65 and older, ...

The rollout of updated Covid vaccines for healthy children and adults this fall is likely to be delayed after the FDA said it ...

FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.

Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the “Company”), comments on the new COVID Vaccine policy adopted by the US FDA.